Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by steadfaston Oct 11, 2014 10:37pm

172 Views

Post# 23022148

RE:Harvard News

Thank you for sharing. Prof MELTON said "We are now just one pre-clinical step away
from the finish line'. The stem cell-derived beta cells are presently undergoing trials in
animal models.

Hopefully, SVA must be closer to the finish line;
2009 - Animal trials started
August 2012 - Human trials started

Looking forward to the comprehensive update expected soon.

Bullboard Posts

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles